Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 30,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $16.09, for a total transaction of $482,700.00. Following the transaction, the president owned 998,813 shares in the company, valued at approximately $16,070,901.17. The trade was a 2.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, April 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.87, for a total transaction of $626,100.00.
• On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.84, for a total transaction of $655,602.16.
• On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.48, for a total transaction of $524,400.00.
• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total transaction of $508,021.85.

Alignment Healthcare Stock Performance

Alignment Healthcare stock opened at $16.36 on Wednesday. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a market cap of $3.38 billion, a PE ratio of 181.78, a PEG ratio of 2.28 and a beta of 1.26. The company’s 50-day moving average is $18.93 and its two-hundred day moving average is $19.44.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, April 30th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the prior year, the company posted ($0.05) EPS. The company’s revenue was up 33.3% compared to the same quarter last year. Equities analysts anticipate that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current year.

Institutional Trading of Alignment Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Summit Securities Group LLC bought a new stake in Alignment Healthcare during the 4th quarter worth approximately $26,000. Parallel Advisors LLC increased its stake in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares in the last quarter. Larson Financial Group LLC bought a new stake in Alignment Healthcare during the 3rd quarter worth approximately $33,000. First Horizon Corp bought a new stake in Alignment Healthcare during the 4th quarter worth approximately $39,000. Finally, GAMMA Investing LLC increased its stake in Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares in the last quarter. 86.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. UBS Group upped their price target on Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. upped their price target on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a research note on Thursday, May 7th. Finally, Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.60.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.